Trident Lifeline stock soars 12% on TLL Herbal stake approval

Trident Lifeline has gained consent from TLL Herbal’s current shareholders to acquire a majority (51% of the company’s shares), converting TLL Herbal into a subsidiary. By constructing a Research & Development cum production facility along with integration facility, the goal of the acquisition is to expand the firm towards new technologies. At their meeting on July 15, 2023, the Board of Directors made the necessary decisions and gave their approval.  

Trident Lifeline Limited, a 2014 incorporation, is involved in the marketing of medicinal products in both domestic and foreign markets. The business also distributes pharmaceuticals through a network of third-party distributors. The company manufactures and markets high-quality finished doses. It is one of the SME segment’s fastest-growing pharmaceutical enterprises, offering healthcare items of unmatched quality. It sells capsules, tablets, liquid ointments, gels, mouthwash, pastes, solutions, suspensions, dry powders, and toothpaste, among other pharmaceutical products. Its product line includes a wide variety of medications, including NSAIDS and anti-fungal, anti-bacterial, anti-diarrheal, anti-fungal, anti-malerial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozol, anti-histamine, anti-hypertensive drugs, anti-lipidemic drugs, and anti-parasitic medications.  

Trident Lifeline is involved in the ethical marketing of pharmaceuticals both domestically and abroad. Additionally, it distributes pharmaceutical items using a network of third-party distributors. It provides a large selection of pharmaceutical formulations and goods made through contract manufacturing with a loan licence. Along with Africa, Latin America, and East Asian nations, it works in India. It is present in nations including Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venuzela through registered products or products that are undergoing registration there. 

Today, the stock opened at Rs 146.00, with a high and low of Rs 160.20 and Rs 146.00. 

Shares closed at Rs 150.00, up by 12.30% from its previous close of Rs 133.50. 

The stock has a 52-week high of Rs 179.95 and a 52-week low of Rs 102.75. 

The current market cap of Trident Lifeline Ltd is Rs 172.49 crore. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet, and is subject to changes. Please consult an expert before making related decisions.